Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 24,635 shares at $81.02 ($2.0M) on 2021-01-11, disclosed to the SEC on 2021-01-12.
Seasonal sale ($2.0M) by Chief Financial Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.02 | 11,597 | $940K | 47.1% |
| 2 | $81.02 | 11,597 | $940K | 47.1% |
| 3 | $81.00 | 1,441 | $117K | 5.8% |
| Total | $81.02 avg | 24,635 | $2.0M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |